Superstock Investor
Member Login   RSS ->
James DiGeorgia, Mr. Macro
- Chief Editor -
Mr. Macro
Geoff Garbacz, Mr. Micro
- Chief Strategist -
Mr. Micro
Dan Hassey, Mr. Retirement
- Senior Stock Analyst -
Mr. Retirement
Superstock Investor


[Printable Version of This Page]

Today's Superstock Investor Stock Scorecard:

Bristol-Myers Squibb Company (BMY)
by Superstock Investor

October 25, 2018

 

We have traded Bristol Myers (BMY) rather successfully in our Morning Matters Portfolio over the years. We sold shares earlier this year for a gain of 25% at $62.24 and the shares are now at $48.83. We also took a 22% gain in 2016. Worth a look again as it beat estimates by $0.18 and raised guidance.

Company Information

Company: Bristol-Myers Squibb Company
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Market Cap:  $98,696,500,000

Targets

  Price %Gain  
Current Price $57.83    
Price Target $57.83 0.0%  
Upper Bound $72.29 25.0%  
Lower Bound $49.16 -15.0%  

Stock data last updated 10/16/2018.

Data provided by QPI, Inc. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. QPI, Inc. is not liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing this page, you agree not to redistribute the information found herein.

Stock Scorecard Archives